Hirofumi Shigeta

951 citations

24 papers · 692 indexed · h-index 14

Clinical Biochemistry top 2%
- Advanced Glycation End Products research 5
Endocrinology, Diabetes and Metabolism top 10%
- Diabetes Management and Research 6
- Natural Antidiabetic Agents Studies 3
Ophthalmology top 5%
Nephrology top 10%
Orthopedics and Sports Medicine top 10%
Genetics
- Diabetes and associated disorders 8
Surgery
- Pancreatic function and diabetes 8
Physiology
- Pain Mechanisms and Treatments 2
Cell Biology
- Aldose Reductase and Taurine 2
Epidemiology
- Adipokines, Inflammation, and Metabolic Diseases 2

Co-authors: Yoshihiro Kitagawa Hiroshi Obayashi Goji Hasegawa Motoharu Kondo Mitsuhiro Fujii Koji Nakano Naoto Nakamura Masataka Nishimura
Cited by: Clinical Biochemistry Endocrinology, Diabetes and Metabolism Ophthalmology
Partner nations: Japan United States Singapore

In The Last Decade

Hirofumi Shigeta

23 papers receiving 661 citations

Peers

Countries citing papers authored by Hirofumi Shigeta

Since Specialization

Citations

This map shows the geographic impact of Hirofumi Shigeta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirofumi Shigeta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirofumi Shigeta more than expected).

Fields of papers citing papers by Hirofumi Shigeta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirofumi Shigeta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirofumi Shigeta. The network helps show where Hirofumi Shigeta may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hirofumi Shigeta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hirofumi Shigeta Line = papers co-authored together Hirofumi Shigeta links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Elevated neutrophil‑to‑lymphocyte ratio is associated with nutritional impairment, immune suppression, resistance to S‑1 plus cisplatin, and poor prognosis in patients with stage?IV gastric cancer Kenji Gonda,Masahiko Shibata,Yu Sato,Maria Washio,Hiroyuki Takeshita,Hirofumi Shigeta,Michikazu Ogura,Oka S,Shinich Sakuramoto	2017	36
2	Effect of teriparatide on bone mineral density and biochemical markers in Japanese women with postmenopausal osteoporosis: a 6-month dose-response study Akimitsu Miyauchi,Toshio Matsumoto,Hirofumi Shigeta,Mika Tsujimoto,D. Thiébaud,Toshitaka Nakamura	2008	41
3	Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Mellitus Prajakti A. Kothare,Helle Linnebjerg,Yoshitaka Isaka,Kazunori Uenaka,Ayuko Yamamura,Kwee Poo Yeo,Amparo de la Peña,Choo Hua Teng,Kenneth Mace,Mark Fineman,Hirofumi Shigeta,Yukikuni Sakata,Shin Irie	2008	53
4	Takao Awa,Tetsushi Nakata,Hirofumi Shigeta	2005	0
5	TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes Masataka Nishimura,Hiroshi Obayashi,Ikuko Mizuta,Hirokazu Hara,Tetsuo Adachi,Mitsuhiro Ohta,Hisataka Tegoshi,Michiaki Fukui,Goji Hasegawa,Hirofumi Shigeta,Yoshihiro Kitagawa,Koji Nakano,Ryuji Kaji,Naoto Nakamura	2003	41
6	Induction of aldose reductase in cultured human microvascular endothelial cells by advanced glycation end products Naoto Nakamura,Hiroshi Obayashi,Mitsuhiro Fujii,Michiaki Fukui,Kuniaki Yoshimori,Masakazu Ogata,Goji Hasegawa,Hirofumi Shigeta,Yoshihiro Kitagawa,Toshikazu Yoshikawa,Motoharu Kondo,Mitsuhiro Ohta,Masataka Nishimura,Toru Nishinaka,Chihiro Nishimura	2000	48
7	Association between type 1 diabetes age-at-onset and intercellular adhesion molecule-1 (ICAM-1) gene polymorphism Masataka Nishimura,Hiroshi Obayashi,Etsuko Maruya,M. Ohta,Hisataka Tegoshi,Michiaki Fukui,Goji Hasegawa,Hirofumi Shigeta,Yoshihiro Kitagawa,Koji Nakano,Hiroh Saji,Naoto Nakamura	2000	44
8	Crossline levels in serum and erythrocyte membrane proteins from patients with diabetic nephropathy Shin-ichiro Aoki,Goji Hasegawa,Hirofumi Shigeta,Hiroshi Obayashi,Mitsuhiro Fujii,Fumiaki Kimura,Akira Moriwaki,Naoto Nakamura,Kazuharu Ienaga,Ko Nakamura,Motoharu Kondo	2000	10
9	Prediction of Diabetes in Biobreeding/Aburahi Rats by the Measurement of Soluble L-Selectin Toru Tanaka,Naoto Nakamura,Yoshihiro Kitagawa,Hirofumi Shigeta,Goji Hasegawa,Hiroshi Obayashi,Masayuki Miyasaka,Hiroyuki Nakao,Susumu Makino,Motoharu Kondo	2000	1
10	Tumor Necrosis Factor Microsatellite Polymorphism Influences the Development of Insulin Dependency in Adult-Onset Diabetes Patients with the DRB1∗1502-DQB1∗0601 Allele and Anti-Glutamic Acid Decarboxylase Antibodies Hiroshi Obayashi,Goji Hasegawa,Michiaki Fukui,Kenji Kamiuchi,Akane Kitamura,Masakazu Ogata,Toshihiro Kanaitsuka,Hirofumi Shigeta,Yoshihiro Kitagawa,Koji Nakano,Masataka Nishimura,Mitsuhiro Ohta,Naoto Nakamura	2000	15
11	Influence of TNF microsatellite polymorphisms (TNFa) on age-at-onset of insulin-dependent diabetes mellitus Hiroshi Obayashi,Naoto Nakamura,Michiaki Fukui,Hisataka Tegoshi,Mitsuhiro Fujii,Masakazu Ogata,Goji Hasegawa,Hirofumi Shigeta,Yoshihiro Kitagawa,Koji Nakano,Motoharu Kondo,Iwao Fukui,Etsuko Maruya,H. Saji,Mitsuhiro Ohta,Masataka Nishimura	1999	30
12	Increased levels of aldose reductase in peripheral mononuclear cells from type 2 diabetic patients with microangiopathy Goji Hasegawa,Hiroshi Obayashi,Akane Kitamura,Masao Hashimoto,Hirofumi Shigeta,Naoto Nakamura,Motoharu Kondo,Chihiro Nishimura	1999	14
13	Ratio of Motor Nerve Conduction Velocity to F-Wave Conduction Velocity in Diabetic Neuropathy Kimiko Ohgaki,Koji Nakano,Hirofumi Shigeta,Yoshihiro Kitagawa,Naoto Nakamura,Kazuhide Iwamoto,Masahiro Makino,Yoshiaki Takanashi,Shizuo Kajiyama,Motoharu Kondo	1998	10
14	HLA-DRB1 Alleles Contribute to Determining the Prognosis of Japanese Diabetes Mellitus Positive for Antibodies to Glutamate Decarboxylase Michiaki Fukui,Koji Nakano,Naoto Nakamura,Etsuko Maruya,Hiroh Saji,Hiroshi Obayashi,Kiyoe Ohta,M. Ohta,Hiroshi Mori,Shizuo Kajiyama,Shigeo Wada,Yasuo Kida,Kitaro Kosaka,Masako Deguchi,Hirofumi Shigeta,Yoshihiro Kitagawa,Motoharu Kondo	1998	9
15	Advanced Glycation End Products Induce Expression of Vascular Endothelial Growth Factor by Retinal Müller Cells Chizuko Hirata,Koji Nakano,Naoto Nakamura,Yoshihiro Kitagawa,Hirofumi Shigeta,Goji Hasegawa,Masakazu Ogata,Tsunehiko Ikeda,Hiroshi Sawa,Ko Nakamura,Kazuharu Ienaga,Hiroshi Obayashi,Motoharu Kondo	1997	94
16	Troglitazone (CS-045) ameliorates albuminuria in streptozotocin-induced diabetic rats Mitsuhiro Fujii,Reiji Takemura,Makiko Yamaguchi,Goji Hasegawa,Hirofumi Shigeta,Koji Nakano,Motoharu Kondo	1997	61
17	Diagnostic Significance of Antibodies to Glutamic Acid Decarboxylase in Japanese Diabetic Patients with Secondary Oral Hypoglycemic Agents Failure Michiaki Fukui,Koji Nakano,Etsuko Maruya,Hiroh Saji,Kiyoe Ohta,Mitsuhiro Ohta,Hiroshi Obayashi,Hiroshi Mori,Shizuo Kajiyama,Shigeo Wada,Hirofumi Shigeta,Yoshihiro Kitagawa,Naoto Nakamura,Motoharu Kondo	1997	10
18	Serum Autoantibodies Against Sulfatide and Phospholipid in NIDDM Patients With Diabetic Neuropathy Hirofumi Shigeta,Makiko Yamaguchi,Koji Nakano,Hiroshi Obayashi,Reiji Takemura,Michiaki Fukui,Mitsuhiro Fujii,Kuniaki Yoshimori,Goji Hasegawa,Naoto Nakamura,Yoshihiro Kitagawa,Motoharu Kondo	1997	17
19	Formation of Crossline as a Fluorescent Advanced Glycation End Productin Vitroandin Vivo Hiroshi Obayashi,Koji Nakano,Hirofumi Shigeta,Makiko Yamaguchi,Kuniaki Yoshimori,Michiaki Fukui,Mitsuhiro Fujii,Yoshihiro Kitagawa,Naoto Nakamura,Ko Nakamura,Yoshitaka Nakazawa,Kazuharu Ienaga,Mitsuhiro Ohta,Masataka Nishimura,Iwao Fukui,Motoharu Kondo	1996	118
20	Effects of aspartame on diabetic rats and diabetic patients. Hirofumi Shigeta,Toshihide Yoshida,Masahiko Nakai,Hiroshi Mori,Yasuyuki KANO,Hitoshi Nishioka,Shizuo Kajiyama,Yoshihiro Kitagawa,Takahiro Kanatsuna,Motoharu Kondo,Kyoko Otsuki	1985	22

About Hirofumi Shigeta

Hirofumi Shigeta is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Genetics, having authored 24 papers that have together received 692 indexed citations. Recurring topics across this work include Diabetes and associated disorders (8 papers), Pancreatic function and diabetes (8 papers), Diabetes Management and Research (6 papers), Advanced Glycation End Products research (5 papers), Natural Antidiabetic Agents Studies (3 papers), Pain Mechanisms and Treatments (2 papers), Aldose Reductase and Taurine (2 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). The work is most often cited by research in Clinical Biochemistry (200 citations), Endocrinology, Diabetes and Metabolism (195 citations) and Ophthalmology (67 citations). Hirofumi Shigeta has collaborated with scholars based in Japan, United States and Singapore. Frequent co-authors include Yoshihiro Kitagawa, Hiroshi Obayashi, Goji Hasegawa, Motoharu Kondo, Mitsuhiro Fujii, Koji Nakano, Naoto Nakamura, Masataka Nishimura, Michiaki Fukui and Ko Nakamura.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact